ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 378 filers reported holding ENCOMPASS HEALTH CORP in Q3 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $227,538 | -10.3% | 3,388 | -9.6% | 0.00% | 0.0% |
Q2 2023 | $253,709 | +126754.5% | 3,747 | +1.3% | 0.00% | 0.0% |
Q1 2023 | $200 | -11.9% | 3,699 | -2.6% | 0.00% | 0.0% |
Q4 2022 | $227 | -99.9% | 3,798 | -10.4% | 0.00% | 0.0% |
Q2 2022 | $238,000 | -29.6% | 4,241 | -10.6% | 0.00% | -33.3% |
Q1 2022 | $338,000 | +17.8% | 4,745 | +8.1% | 0.00% | +50.0% |
Q4 2021 | $287,000 | -53.0% | 4,389 | -46.1% | 0.00% | -60.0% |
Q3 2021 | $610,000 | -22.1% | 8,139 | -18.9% | 0.01% | -28.6% |
Q2 2021 | $783,000 | +107.7% | 10,034 | +118.4% | 0.01% | +133.3% |
Q1 2021 | $377,000 | +18.6% | 4,595 | +19.5% | 0.00% | 0.0% |
Q4 2020 | $318,000 | +27.7% | 3,844 | +0.3% | 0.00% | 0.0% |
Q3 2020 | $249,000 | +8.3% | 3,831 | +3.4% | 0.00% | 0.0% |
Q2 2020 | $230,000 | -40.3% | 3,705 | -43.8% | 0.00% | -25.0% |
Q1 2019 | $385,000 | -10.5% | 6,594 | -5.4% | 0.00% | -20.0% |
Q4 2018 | $430,000 | -26.0% | 6,969 | -6.5% | 0.01% | -16.7% |
Q3 2018 | $581,000 | +4.3% | 7,451 | -9.4% | 0.01% | 0.0% |
Q2 2018 | $557,000 | +16.8% | 8,228 | -1.4% | 0.01% | +20.0% |
Q1 2018 | $477,000 | – | 8,349 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |